Company Filing History:
Years Active: 2013-2025
Title: The Innovations of Jill Fredrickson in Medical Imaging and Antibody Development
Introduction: Jill Fredrickson is a notable inventor based in Sunnyvale, California. With an impressive portfolio of three patents, she has made significant contributions in the fields of medical imaging and immunology. Her work demonstrates the intersection of technology and healthcare, showcasing how innovative solutions can enhance patient diagnosis and treatment.
Latest Patents: Jill's latest patents reflect her expertise and commitment to advancing medical technology. One of her groundbreaking inventions is titled "Deep Convolutional Neural Networks for Tumor Segmentation with Positron Emission Tomography." This patent details techniques for accurately segmenting tumors using deep convolutional neural networks, which enhances image analysis for lesions in patients. By utilizing both positron emission tomography (PET) and computerized tomography (CT) or magnetic resonance imaging (MRI) scans, her work allows for preprocessing of images and the generation of standardized images. This process involves creating two-dimensional and three-dimensional segmentation masks that significantly improve the precision of tumor location and analysis.
Another notable patent is "Humanized Anti-EGFL7 Antibodies and Methods Using Same." This invention focuses on developing antibodies targeting EGFL7, providing new therapeutic approaches that could potentially lead to better treatment outcomes for patients.
Career Highlights: Jill Fredrickson's career is closely associated with Genentech, Inc., a leading biotech company known for its innovations in medicine. Her role at Genentech underscores her dedication to research and development in the healthcare field.
Collaborations: Throughout her career, Jill has collaborated with esteemed colleagues, including Weilan Ye and Mark S. Dennis. These partnerships highlight the importance of teamwork in advancing scientific research and the development of cutting-edge medical solutions.
Conclusion: Jill Fredrickson's contributions to the fields of medical imaging and antibody development exemplify the power of innovation in health technology. Her patents not only enhance our understanding of tumor segmentation and treatment but also illustrate the vital role inventors play in improving healthcare systems. As her work continues to evolve, it remains an inspiring testament to the impact of dedicated innovation in medicine.